(19)
(11) EP 1 598 366 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.03.2009 Bulletin 2009/12

(45) Mention of the grant of the patent:
20.08.2008 Bulletin 2008/34

(21) Application number: 05101866.1

(22) Date of filing: 10.03.2005
(51) International Patent Classification (IPC): 
C07K 14/655(2006.01)
A61P 35/00(2006.01)
 A61K 38/31(2006.01)

(54)

Somatostatin analogues

Analoge des Somatostatin

Analogues de la somatostatine

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

(30) Priority: 10.03.2004 IT FI20040057

(43) Date of publication of application:
23.11.2005 Bulletin 2005/47

(73) Proprietor: Advanced Accelerator Applications S.A.
01630 Saint Genis Pouilly (FR)

(72) Inventors:
  • Giuntini, Mauro
    50139 Firenze (IT)
  • Ginanneschi, Mauro
    59100 Prato (IT)
  • Chelli, Mario
    50064 Incisa Val d'Arno (IT)
  • Papini, Anna Maria
    50127 Firenze (IT)

(74) Representative: Gervasi, Gemma et al
Notarbartolo & Gervasi S.p.A. Corso di Porta Vittoria, 9
20122 Milano
20122 Milano (IT)


(56) References cited: : 
US-A1- 2002 052 315
   
  • WHELAN A N ET AL: "A tandem metathesis-hydrogenation route to dicarba analogues of cystine-containing cyclic peptides" TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 45, no. 52, 20 December 2004 (2004-12-20), pages 9545-9547, XP004718540 ISSN: 0040-4039
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).